STERIS executive shares withheld for tax on vesting

STERIS plc senior executive Julia Madsen reported a routine tax-withholding transaction linked to restricted share vesting.

Rhea-AI Filing Summary

STERIS plc senior executive Julia Madsen reported a routine tax-withholding transaction linked to restricted share vesting. On June 3, 2026, 239 ordinary shares valued at $210.19 per share were withheld from 666 restricted shares that vested, to cover taxes determined under applicable laws using the NYSE closing price.

After this withholding, Madsen directly held 12,452 ordinary shares, including 4,732 restricted shares as of June 3, 2026. These restricted shares are scheduled to lapse in stages between June 4, 2026 and June 4, 2029.

Insider Trade Summary

Exercise Price or Tax Liability: 239 shares

Exercise Price or Tax Liability 1 txn

Insider Madsen Julia

Role Sr. VP and GM, Life Sciences

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Ordinary Shares	239	$210.19	$50K

Holdings After Transaction: Ordinary Shares — 12,452 shares (Direct)

Footnotes (2)

1. F1. 239 shares were withheld from the 666 restricted shares that vested on June 3, 2026. These 239 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 3, 2026.
2. F2. As of June 3, 2026, 4,732 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 542 on June 4, 2026; 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029.

Key Figures

Tax-withheld shares: 239 shares Withholding share price: $210.19 per share Vested restricted shares: 666 shares +3 more

6 metrics

Tax-withheld shares 239 shares Shares withheld on June 3, 2026 to cover taxes

Withholding share price $210.19 per share NYSE closing price on June 3, 2026 for tax valuation

Vested restricted shares 666 shares Restricted shares that vested on June 3, 2026

Shares after transaction 12,452 shares Ordinary shares directly held following the disposition

Restricted shares outstanding 4,732 shares Restricted ordinary shares as of June 3, 2026

Future vesting tranche 772 shares Restrictions lapse on June 4, 2029

Key Terms

restricted shares, taxes required to be withheld, NYSE closing market price, restrictions on these ordinary shares lapse, +1 more

5 terms

restricted shares financial

"239 shares were withheld from the 666 restricted shares that vested on June 3, 2026."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

taxes required to be withheld financial

"These 239 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer."

NYSE closing market price financial

"These vested shares were valued at the NYSE closing market price on June 3, 2026."

restrictions on these ordinary shares lapse financial

"The restrictions on these ordinary shares lapse as follows: 542 on June 4, 2026; 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029."

Sr. VP and GM, Life Sciences financial

"officer_title": "Sr. VP and GM, Life Sciences""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did STERIS (STE) report for Julia Madsen?

STERIS reported that senior vice president Julia Madsen had 239 ordinary shares withheld on June 3, 2026. These shares were used to satisfy tax obligations arising from the vesting of 666 restricted shares granted as equity compensation.

Was the STERIS (STE) Form 4 a market sale of shares?

No, the Form 4 shows a tax-withholding disposition, not an open-market sale. 239 shares were withheld by the company to cover required taxes when 666 restricted shares vested on June 3, 2026.

How many STERIS (STE) shares does Julia Madsen hold after the transaction?

After the June 3, 2026 transaction, Julia Madsen directly holds 12,452 STERIS ordinary shares. This total includes both unrestricted and 4,732 restricted shares that will vest over multiple future dates.

What restricted STERIS (STE) shares are still unvested for Julia Madsen?

As of June 3, 2026, 4,732 of Julia Madsen’s STERIS ordinary shares remain restricted. These restrictions are scheduled to lapse in several tranches between June 4, 2026 and June 4, 2029, according to the disclosed vesting schedule.

At what price were the withheld STERIS (STE) shares valued for taxes?

The 239 withheld shares were valued at the NYSE closing market price on June 3, 2026. That closing price was $210.19 per share and was used to determine the tax-withholding amount on the vested restricted shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 04:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Madsen Julia

(Last) (First) (Middle)

70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 D02 R296

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. VP and GM, Life Sciences

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/03/2026		F		239(1)	D	$210.19	12,452(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 239 shares were withheld from the 666 restricted shares that vested on June 3, 2026. These 239 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 3, 2026.

2. As of June 3, 2026, 4,732 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 542 on June 4, 2026; 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)